CTT Pharmaceutical Holdings Inc. Stock Analysis CTTH

CTT Pharmaceutical Holdings, Inc. engages in the development of drug delivery systems technology within the pharmaceutical industry. The company is headquartered in Tampa, Florida. Its technology platform includes the development of advanced oral delivery thin wafers to deliver treatment as an alternate to smoking and ingestion. The wafer is an orally administrable paper-thin polymer film used as a carrier for pharmaceutical agents. The company rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its oral film technology drug delivery system can be provided in various packaging configurations, ranging from unit-dose pouches to multiple-dose blister packages. Its drug delivery system technology includes nicotine, vitamins, pharmaceuticals, and many other actives. The company offers oral thin strips for pain management and inflammation indications, such as arthritis. VetWafe is used for pain management for pet markets. The company is a thin film for treating dogs and cats.